BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Sun SP, Jin YN, Yang HP, Wei Y, Dong Z. Serum transforming growth factor-β1 level reflects disease status in patients with esophageal carcinoma after radiotherapy. World J Gastroenterol 2007; 13(39): 5267-5272 [PMID: 17876899 DOI: 10.3748/wjg.v13.i39.5267]
URL: https://www.wjgnet.com/1007-9327/full/v13/i39/5267.htm
Number Citing Articles
1
Dylan P. McClurg, Chandan Sanghera, Somnath Mukherjee, Rebecca C. Fitzgerald, Christopher M. Jones. A systematic review of circulating predictive and prognostic biomarkers to aid the personalised use of radiotherapy in the radical treatment of patients with oesophageal cancerRadiotherapy and Oncology 2024; 195: 110224 doi: 10.1016/j.radonc.2024.110224
2
Jayasree Talukdar, Kangkana Kataki, Eyashin Ali, Bikash Narayan Choudhury, Munindra Narayan Baruah, Mallika Bhattacharyya, Sahana Bhattacharjee, Subhash Medhi. Altered expression of TGF-β1 and TGF-βR2 in tissue samples compared to blood is associated with food habits and survival in esophageal squamous cell carcinomaCurrent Problems in Cancer 2021; 45(1): 100617 doi: 10.1016/j.currproblcancer.2020.100617
3
Chia-Chi Lin, Toshihiko Doi, Kei Muro, Ming-Mo Hou, Taito Esaki, Hiroki Hara, Hyun Cheol Chung, Christoph Helwig, Isabelle Dussault, Motonobu Osada, Shunsuke Kondo. Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGFβ and PD-L1, in Patients with Esophageal Squamous Cell Carcinoma: Results from a Phase 1 Cohort in AsiaTargeted Oncology 2021; 16(4): 447 doi: 10.1007/s11523-021-00810-9
4
Yu-Lei Hou, Hui Chen, Zi-He Dong, Cheng-Jun Xue, Yan-Feng Wu, Hai-Xia Luo, Yong-Chang Wu, Cheng-Hua Li. Clinical significance of serum transforming growth factor-β1 in lung cancerCancer Epidemiology 2013; 37(5): 750 doi: 10.1016/j.canep.2013.04.013
5
Jingwen Luo, Xu-Qiao Chen, Ping Li. The Role of TGF-β and Its Receptors in Gastrointestinal CancersTranslational Oncology 2019; 12(3): 475 doi: 10.1016/j.tranon.2018.11.010
6
Shao-Lun Lu, Feng-Ming Hsu, Chiao-Ling Tsai, Jian-Kuan Wu, Jang-Ming Lee, Pei-Ming Huang, Chih-Hung Hsu, Albert C. Koong, Daniel T. Chang, Jason Chia-Hsien Cheng. Serum Transforming Growth Factor-β1 Change After Neoadjuvant Chemoradiation Therapy Is Associated With Postoperative Pulmonary Complications in Esophageal Cancer Patients Undergoing Combined Modality TherapyInternational Journal of Radiation Oncology*Biology*Physics 2015; 93(5): 1023 doi: 10.1016/j.ijrobp.2015.08.035
7
Stephen P. Malkoski, Jessyka G. Lighthall, Xiao-Jing Wang. Oral Cancer Metastasis2009; : 163 doi: 10.1007/978-1-4419-0775-2_8
8
Ionizing Radiation Promotes Migration and Invasion of Cancer Cells Through Transforming Growth Factor-Beta–Mediated Epithelial–Mesenchymal TransitionInternational Journal of Radiation Oncology*Biology*Physics 2011; 81(5): 1530 doi: 10.1016/j.ijrobp.2011.06.1956
9
Jason Chia-Hsien Cheng, Madeline S. Graber, Feng-Ming Hsu, Chiao-Ling Tsai, Leon Castaneda, Jang-Ming Lee, Daniel T. Chang, Albert C. Koong. High Serum Levels of Vascular Endothelial Growth Factor-A and Transforming Growth Factor-β1 Before Neoadjuvant Chemoradiotherapy Predict Poor Outcomes in Patients with Esophageal Squamous Cell Carcinoma Receiving Combined Modality TherapyAnnals of Surgical Oncology 2014; 21(7): 2361 doi: 10.1245/s10434-014-3611-z
10
Pınar Ö. Eser, Pasi A. Jänne. TGFβ pathway inhibition in the treatment of non-small cell lung cancerPharmacology & Therapeutics 2018; 184: 112 doi: 10.1016/j.pharmthera.2017.11.004
11
Ana E. González‐Santiago, Luz A. Mendoza‐Topete, Francisco Sánchez‐Llamas, Rogelio Troyo‐Sanromán, Carmen M. Gurrola‐Díaz. TGF‐β1 serum concentration as a complementary diagnostic biomarker of lung cancer: establishment of a cut‐point valueJournal of Clinical Laboratory Analysis 2011; 25(4): 238 doi: 10.1002/jcla.20465
12
J.S. Good, K.J. Harrington. The Hallmarks of Cancer and the Radiation Oncologist: Updating the 5Rs of RadiobiologyClinical Oncology 2013; 25(10): 569 doi: 10.1016/j.clon.2013.06.009